Vol. 19 No. 2 (2020)
Literature Review

Pulmonary and central nervous system infiltration of chronic lymphocytic leukemia with concomitant diffuse large B-cell lymphoma: Case report and review of literature

PDF
  • Saulo F. D. Batista,
  • Karina V. de Melo,
  • Patricia Horn,
  • Vinicius da C. Lisboa,
  • Ana Sheila Cypriano,
  • Andrea Pires,
  • Marilza de M. Ribeiro-Carvalho,
  • Fábio Santiago,
  • Maria Helena F. O. de Souza
DOI: https://doi.org/10.12957/bjhbs.2020.59716

Published 2021-01-04

Keywords

  • Chronic lymphoid leukemia (CLL),
  • Diffuse large B-cell lymphoma (DLBCL),
  • Central Nervous System infiltra-tion,
  • Pulmonary infiltration

How to Cite

1.
F. D. Batista S, V. de Melo K, Horn P, da C. Lisboa V, Cypriano AS, Pires A, de M. Ribeiro-Carvalho M, Santiago F, F. O. de Souza MH. Pulmonary and central nervous system infiltration of chronic lymphocytic leukemia with concomitant diffuse large B-cell lymphoma: Case report and review of literature. BJHBS [Internet]. 2021 Jan. 4 [cited 2024 Oct. 11];19(2):124-9. Available from: https://bjhbs.hupe.uerj.br/bjhbs/article/view/78

Copyright (c) 2020 Brazilian Journal of Health and Biomedical Sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Crossref
Scopus
Google Scholar
Europe PMC

Abstract

Introduction: Diffuse large B-cell lymphoma (DLBCL) and chronic lymphoid leukemia (CLL) are lymphoproliferative diseases of B lymphocytes. Objective: To describe the con-comitance of diseases with pulmonary and CNS involvement. Clinical case: A 67-year-old patient with DLBCL and CLL obtained partial remission of the diseases after six cycles of standard combined chemotherapy. Relapse of CLL (del17p; TP53+) occurred after 22 months, becoming refractory to a new treatment. Monoclonal B lymphocyte infiltration was found in the cerebrospinal fluid and bronchoalveolar lavage, leading to death due to respiratory failure. Conclusion: The unfavorable outcome shows a rare and serious complication in the concomitance of these diseases.

PDF

Metrics

Metrics Loading ...

References

  1. Chastain EC, Duncavage EJ. Clinical prognostic biomarkers biomarkers in chronic lymphocytic leukemia and diffuse large B-cell lymphoma.Arch Pathol Lab Med. 2015;139(5): 602–7.
  2. Swerdlow SH, Campo E, Pileri SA, et al. Who Classification of tumours of Haematopoietic and lymphoid Tissues. IARC, Lyon 2017.
  3. Hallek M, Shanafelt TD, Eichhorst B. Chronic lymphocytic leukaemia. Lancet. 2018;391(10129):1524–1537.
  4. Rai KR, Sawitsky A, Cronkite EP, et al. Clinical staging of chron-ic lymphocytic leukemia. Blood. 1975;46(2):219–234.
  5. NCCN Clinical Practice Guidelines in Oncology. Chronic lym-phocytic leukemia/small lymphocytic lymphoma, version 4.2020. National Comprehensive Cancer Network website. Nccn.org/professionals/physician_gls/pdf/cll.pdf. Accessed April 22, 2020.
  6. Ratterman M, Kruczek K, Sulo S, et al. Extramedullary chronic lymphocytic leukemia: systematic analysis of cases reported between 1975 and 2012. Leuk Res. 2014;(38):299–303.
  7. Abuelgasim KA, Rehan H, Alsubaie M, et al. Coexistence of chronic myeloid leukemia and diffuse large B-cell lymphoma with antecedent chronic lymphocytic leukemia: a case report and review of the literature. J Med Case Rep. 2018;(12):641.
  8. Ornellas MHF, Fernandez TS, Diamond HR, et al. Cytogenetic and immunophenotypic evidence of independent clonal origins of concomitant chronic lymphocytic leukaemia and acute myeloid leukaemia. European Journal of Haematology. 2001;(66):281–283.
  9. Langer S, Dass J, Mittal S, et al. Concomitant Presence of CD5-Positive Diffuse Large B-Cell Lymphoma and Monoclonal B Cells with the “CLL Immunophenotype” - Is It Richter’s Trans-formation? Turk J Haematol. 2017;34(2):188–190.
  10. Wei Q, Sebastian S, Papavassiliou P, et al. Metachronous/ con-comitant B-cell neoplasms with discordant light-chain or heavy-chain isotype restrictions: evidence of distinct B-cell neoplasms rather than clonal evolutions. Hum Pathol. 2014;(45):2063–2076
  11. Anderson JR, Armitage JO, Weisenburger D. Epidemiology of the non-Hodgkin’s lymphomas: Distributions of the major subtypes differ by geographic locations. Annals of Oncology 1998;(9):717–72.
  12. Porcu P, Cripe LD, Ng EW, et al. Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presenta-tion and management. Leuk Lymphoma. 2000;39(1-2):1–18.
  13. Wąsik-Szczepanek E, Szymczyk A, Szczepanek D. et al. Richter syndrome: rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma. Adv Clin Exp Med. 2018;27(12):1683–1689.
  14. Parikh AS, Shanafelt TD. Risk Factors for Richter Syndrome in Chronic Lymphocytic Leukemia. Curr Hematol Malig Rep. 2014;(9):294–299.
  15. Catherwood MA, Gonzalez D, Donaldson D, et al. Relevance of TP53 for CLL diagnostics. J Clin Pathol. 2019;72(5):343–346.
  16. Campo E, Cymbalista F, Ghia P, et al. TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics. Haematologica. 2018;103(12):1956–1968.
  17. Strati P, Shanafelt TD. Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification. Blood. 2015 Jul 23;126(4):454–62.
  18. Strati P, Uhum HJ, Kaulfmann TJ, et al. Prevalence ad Charac-terisitics Of Central Nervous System Involvement by Chronic Lymphocytic Leukemia. Haematologica. 2016; 4.
  19. Lopes da Silva R. Spectrum of neurologic complications in chronic lymphocytic leukemia. Clin Lymphoma Myeloma Leuk. 2012;(12):164–179.
  20. Souza SL, Santiago F, Ribeiro-Carvalho M, et al. Leptome-ningeal involvement in B-cell chronic lymphocytic leukemia: a case report and review of the literature. BMC Res Notes. 2014;(3)7:645.
  21. Wanquet A, Birsen A, Choquet S, at al. Central Nervous System Involvement in Chronic Lymphocytic Leukemia: Diagnosis and Treatment in a Retrospective Cohort of Thirty Patients. Ameri-can Society of Hematology, 2015; 12(3).
  22. Wanquet A, Birsen R, Lemal R, et al. Ibrutinib responsive central nervous system involvement in chronic lymphocytic leukemia. Blood. 2016 May 12;127(19):2356-8.
  23. Barcos M, Lane W, Gomez GA, et al. An autopsy study of 1206 acute and chronic leukemias (1958 to 1982). Cancer. 1987 Aug 15;60(4):827-37.